Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 2192-20-3
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15DAY
Supply Ability: G,KG,TON
CAS NO:: |
2192-20-3 |
Appearance:: |
Powder |
Molecular Formula:: |
C21H29Cl3N2O2 |
Molecular Weight:: |
447.82600 |
EINECS NO:: |
218-586-3 |
MDL NO:: |
MFCD00058200 |
CAS NO:: |
2192-20-3 |
Appearance:: |
Powder |
Molecular Formula:: |
C21H29Cl3N2O2 |
Molecular Weight:: |
447.82600 |
EINECS NO:: |
218-586-3 |
MDL NO:: |
MFCD00058200 |
Product Description:
Product Name: Hydroxyzine 2HCl CAS NO: 2192-20-3
Synonyms:
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol,dihydrochloride;
hydroxyzine hydrochloride;
Hydroxyzine dihydrochloride;
Chemical & Physical Properties:
Appearance: Powder
Assay :≥99.0%
Density: 1.182 g/cm3
Boiling Point: 499.2℃ at 760 mmHg
Melting Point: 190-192℃
Flash Point: 255.7℃
Storage Condition: Refrigerator
Vapor Pressure: 8.78E-11mmHg at 25℃
Safety Information:
RTECS: KK2280000
Safety Statement: S26
HS Code: 2933990090
WGK Germany: 3
Risk Statements: R22; R36/37/38
Hazard Code: Xn
H1 receptor antagonist. Anxiolytic. Antihistaminic. Hydroxyzine Dihydrochloride is a histamine H1-receptor antagonist.Target: Histamine H1-ReceptorHydroxyzine inhibits carbachol (10 μM)-induced serotonin release by 34% at 10 μM, by 25% 1 μM and by 17% 0.1 μM in pretreated bladder slices for 60 min. Hydroxyzine (0.1 mM) treatment inhibits the progression and severity of EAE by 50% and the extent of mast cell degranulation by 70% in Lewis rats with allergic encephalomyelitis (EAE). Hydroxyzine (500 M) significantly increases transport of etoposide to the serosal site in the jejunal everted sacs. Hydroxyzine significantly reduces the efflux and approximately 2.4 g/mL of etoposide in the jejunum and ileum. Hydroxyzine (0.2 μg/mL) significantly enhances the efflux of RH123 to the lumen [3].Hydroxyzine (500 μM) significantly decreases the steady-state etoposide concentration 2-fold, where the steady-state concentration reached about 0.055 μM/mL in Sprague-Dawley rats. Hydroxyzine (12.5 mg/kg, 25 mg/kg and 50 mg/kg i.p.) shows little direct analgesic activity but markedly potentiates only the effect of Morphin/e on the vocalization after-discharge which represents the affective component of pain in rats. Hydroxyzine (50 mg/kg i.p.) potentiates Morphin/e on the tail-flick test, while Hydroxyzine (12.5 mg/kg i.p.) decreases Morphin/e antinociception in rats.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.